Stocks making the biggest moves midday: Horizon Therapeutics, Coupa Software, Weber and more

Australia News News

Stocks making the biggest moves midday: Horizon Therapeutics, Coupa Software, Weber and more
Australia Latest News,Australia Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

These are the stocks posting the largest moves in midday trading.

– Shares of Tesla fell more than 4% after a YouGov survey showed that negative views of the electric vehicle maker have overtaken positive ones just slightly. Tesla's brand has deteriorated after CEO Elon Musk took over Twitter.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves in the premarket: Horizon Therapeutics, Coupa Software, Rivian and moreStocks making the biggest moves in the premarket: Horizon Therapeutics, Coupa Software, Rivian and moreThe stocks making the biggest moves in premarket trading include Horizon Therapeutics, Coupa Software, Rivian, and more.
Read more »

Amgen to buy Horizon Therapeutics in $26.4B dealAmgen to buy Horizon Therapeutics in $26.4B dealAmgen is spending more than $26 billion to dive deeper into rare disease treatments with the acquisition of drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a treatment for thyroid eye disease that generated more than $1 billion in its first full year on the market.
Read more »

Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billionAmgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billionAmgen Inc. undefined said Monday it has agreed to acquire Horizon Therapeutics Plc undefined in an all-cash deal valued at $27.8 billion, confirming earlier...
Read more »

Amgen Agrees to Deal to Buy Horizon TherapeuticsAmgen Agrees to Deal to Buy Horizon TherapeuticsThe U.S. biotech company agreed to buy drugmaker Horizon Therapeutics in a deal valued at $27.8 billion, marking the largest healthcare merger of the year.
Read more »

WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsWSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon TherapeuticsAmgen is in advanced talks to buy drugmaker Horizon Therapeutics, people familiar with the matter say, in a deal likely to be valued at well over $20 billion
Read more »

Amgen reportedly in talks to buy Horizon TherapeuticsAmgen reportedly in talks to buy Horizon TherapeuticsThe U.S. biotechnology company AMGN was the last of three suitors standing in an auction for Horizon, according to sources cited by The Wall Street Journal.
Read more »



Render Time: 2025-02-28 02:51:21